Mariana Souza da Silveira

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Centro de Ciências da Saúde

Unidade:

Instituto de Biofísica Carlos Chagas Filho

Departamento:

Programa Neurobiologia/Biof

e-mail:

silveira@biof.ufrj.br

Linkedin:

Google Scholar:

ORCID:

não disponível no Lattes

Formação:
  • Instituto de biofísica Carlos Chagas Filho

    | Pós-Doutorado | 2002 - 2002
  • Instituto de biofísica Carlos Chagas Filho

    | Pós-Doutorado | 2002 - 2006
  • Universidade Federal do Rio de Janeiro

    Ciências Biológicas (Biofísica) | Doutorado | 1998 - 2002
  • Universidade Federal do Rio de Janeiro

    Curso de Bacharelado em Microbiologia e Imunologia | Graduação | 1994 - 1997
  • Escola Técnica Federal de Quimica do Rio de Janeiro

    Curso Técnico em Biotecnologia | Ensino Profissional de nível técnico | 1990 - 1993
Laboratórios:
Nenhum laboratório cadastrado
Nuvens de Palavras:
Artigos:

(96.00% artigos com DOI)

Titulo DOI Ano
The Healthy and Diseased Retina Seen through Neuron-Glia Interactions 10.3390/ijms25021120 2024
Mechanical actuators in microglia dynamics and function 10.1016/j.ejcb.2022.151247 2022
Morphofunctional programming of microglia requires distinct roles of type myosins 10.1002/glia.24067 2021
Dopamine signaling impairs ROS modulation by mitochondrial hexokinase in human neural progenitor cells 10.1042/bsr20211191 2021
Energization by multiple substrates and calcium challenge reveal dysfunctions in brain mitochondria in a model related to acute psychosis 10.1007/s10863-019-09816-5 2020
On the Generation and Regeneration of Retinal Ganglion Cells 10.3389/fcell.2020.581136 2020
De novo genesis of retinal ganglion cells by targeted expression of Klf4 in vivo 10.1242/dev.176586 2019
Substrain-related dependence of Cu(I)-ATPase activity among prion protein-null mice 10.1016/j.brainres.2019.146550 2019
Evidence of Müller Glia Conversion Into Retina Ganglion Cells Using Neurogenin2 10.3389/fncel.2018.00410 2018
Pleiotropic Functions of Pituitary Adenylyl Cyclase-Activating Polypeptide on Retinal Ontogenesis: Involvement of KLF4 in the Control of Progenitor Cell Proliferation 10.1007/s12031-014-0299-2 2014
Pluripotent stem cells as a model to study oxygen metabolism in neurogenesis and neurodevelopmental disorders 10.1016/j.abb.2012.10.009 2013
Avoiding Pitfalls of Internal Controls: Validation of Reference Genes for Analysis by qRT-PCR and Western Blot throughout Rat Retinal Development 10.1371/journal.pone.0043028 2012
Pituitary Adenylyl Cyclase-Activating Polypeptide receptor resensitization induces plastic changes in the dopaminergic phenotype in the mature avian retina 10.1111/jnc.12121 2012
Altered oxygen metabolism associated to neurogenesis of induced pluripotent stem cells derived from a schizophrenic patient 10.3727/096368911X600957 2011
Pituitary adenylyl cyclase-activating polypeptide controls the proliferation of retinal progenitor cells through downregulation of cyclin D1 10.1111/j.1460-9568.2010.07286.x 2010
Macrophage migration inhibitory factor is critical to interleukin-5-driven eosinophilopoiesis and tissue eosinophilia triggered by Schistosoma mansoni infection. 10.1096/fj.08-124248 2009
A conserved domain of the gp85/trans-sialidase family activates host cell extracellular signal-regulated kinase and facilitates Trypanosoma cruzi infection. 10.1016/j.yexcr.2006.10.008 2007
Hop/STI1 modulates retinal proliferation and cell death independent of PrPC 10.1016/j.bbrc.2007.07.038 2007
Neuroprotection by cAMP: Another brick in the wall 10.1007/0-387-30128-3 2006
Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) can act as a determinant of the tyrosine hydroxylase phenotype of dopaminergic cells during retinal development. 10.1016/j.devbrainres.2005.02.016 2005
Control of programmed cell death by neurotransmitters and neuropeptides in the developing mammalian retina. 10.1016/j.preteyeres.2004.10.001 2005
NMDA receptor activation modulates programmed cell death during early postnatal retinal development: A BDNF-dependent mechanism. 10.1111/j.1471-4159.2005.03360.x 2005
Neuritogenesis and neuronal differentiation promoted by 2,4-dinitrophenol, a novel anti-amyloidogenic compound 10.1096/fj.05-3812com 2005
Pituitary adenylyl cyclase- activating polypeptide prevents induced cell death in retinal tissue through activation of cyclic AMP-dependent protein kinase 10.1074/jbc.M110106200 2002
Characterization of Plasmodium falciparum isolated from the Amazon Region of Brazil: evidence for quinine resistance. 1998
Eventos:

(0.00% eventos com DOI)

Titulo DOI Ano
INVESTIGATION OF THE ROLE OF THE TRANSCRIPTION FACTOR KLF4 IN THE PROLIFERATION OF RETINAL PROGENITORS. 2011
Investigation on the role of the Transcription Factor KLF4 in the proliferation of retinal progenitors 2011
Interplay between the neuropeptide PACAP and SHH in the control of cell proliferation in the developing retina 2011
ANALYSIS OF THE EXPRESSION PATTERN OF KLF TRANSCRIPTION FACTORS IN THE DEVELOPING RETINA. 2010
Investigation of the Role of the Transcription Factor Klf4 in the Proliferation of Retinal Progenitors. 2009
Cyclin D1 downregulation in PACAP antiproliferative effect 2006
Neuropeptides and retinal development: multiple roles for PACAP. 2005
PACAP IS AN ANTI-PROLIFERATIVE NEUROACTIVE PEPTIDE IN THE DEVELOPING RETINA. 2005
PACAP is an anti-proliferative neuroactive peptide in the developing retina. 2004
Neuritogenesis and cell dierentiation induced by 2,4-Dinitrophenol, a novel anti-amyloidogenic compound 2004
Mechanisms of neuroprotection by novel anti-amyloidogenic drugs: possible involvement of protein kinase A (PKA) 2004
Characterization of VIP neuroprotective effect in the developing retina. 2003
PACAP and VIP prevent cell death in the developing retinal tissue 2002
Neuroactive peptides modulate cell death in rat retina 2002
Neuroactive peptides prevent cell death in retinal tissue. 2001
Pituitary adenylate cyclase activating polypeptide (PACAP) prevents induced cell death through cyclic AMP-dependent protein kinase in retinal tissue. 2001
Neuroactive peptides prevent induced cell death in retinal tissue. 2001
Neuroactive peptides prevent induced cell death in retinal tissue. 2001
Anti-apoptotic effects of neuroactive peptides in retinal tissue. 2000
BAD e sobrevivência celular na retina em desenvolvimento. 1999
Anti-Apoptotic effects of neuroactive peptides in retinal tissue. 1999
Characterization of Plasmodium falciparum isolated from the Amazon Region of Brazil: evidence for quinine resistance. 1998
Evaluation of MDR-like gene - pfmdr1 - in drug resistant Plasmodium falciparum isolates from the Amazon Region. 1997
Identificação e caracterização de genes envolvidos com a resistência a quinina. 1997
Avaliação Genotípica da resistência a drogas em isolados de Plasmodium falciparum da Região Amazônica. 1996
Avaliação Genotípica da resistência a drogas em isolados de Plasmodium falciparum da Região Amazônica. 1996
Inibição da produção de enterotoxinas após indução do gene mecA em Staphylococcus aureus. 1996
Genotypic evaluation of drug resistant Plasmodium falciparum isolates from the Amazon Region. 1996
Characterization of Plasmodium falciparum isolated from the Amazon Region of Brazil: evidence for quinine resistance. 1996
Genotypic Evaluation of Drug resistant Plasmodium falciparum isolates from the Amazon region. 1996
Predomínio de clones distintos de Staphylococcus aureus multi-resistentes em hospedeiros específicos. 1995
Discriminação entre as classes de resistência à meticilina em Staphylococcus aureus isolados no Brasil 1994
Análise do genoma de Staphylococcus aureus resistentes à meticilina isolados de um hospital no Rio de Janeiro 1994
Discriminação entre as classes de resistência à meticilina em Staphylococcus aureus isolados do Brasil 1993
Publicações:
Minha Rede: